GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Index / LCLabs / Bortezomib, Free Base /Product Detail : B-1408 Bortezomib, Free Base
Related keywords:

#B-1408 Bortezomib, Free Base

Ask technical file .

  Price : 263   EUR
298   USD
204   GBP
1105   Zloty
35212   JPY
2029   NOK
2174   SEK
297   CHF

Product name : Bortezomib, Free Base

Catalog number : B-1408

Quantity: 50 mg

Availability: Yes

Supplier name : LCLabs

ask pdf gentaur products Data sheet : Ask more or other datasheet now !

Contact us about this product :

Our team will respond you as soon as possible !

Email :
Skype :
Name :
Phone :
address :
Question, Comment :
arrow security gentaurPlease retype this code below :
LCLabs \ Bortezomib,_Free_Base \ B_1408
Reload Image

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products : Bortezomib, Free Base


Gentaurpub

Pathways :
WP1625: Base excision repair
WP1787: Base Excision Repair

Related Genes :
[LCB4 YOR171C O3615] Sphingoid long chain base kinase 4 (LCB kinase 4) (EC 2.7.1.91) (Sphinganine kinase 4)
[FREE1 FYVE1 At1g20110 T20H2.10] Protein FREE1 (FYVE domain protein required for endosomal sorting 1) (FYVE domain-containing protein 1)
[LCB5 YLR260W] Sphingoid long chain base kinase 5 (LCB kinase 5) (EC 2.7.1.91) (Sphinganine kinase 5)
[LCB2a LCB2 At5g23670 MQM1.6] Long chain base biosynthesis protein 2a (AtLCB2a) (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (AtLCB2)
[FFAR2 FFA2 GPCR43 GPR43] Free fatty acid receptor 2 (G-protein coupled receptor 43)
[FFAR3 GPR41] Free fatty acid receptor 3 (G-protein coupled receptor 41)
[Ffar2 Gpr43 Lssig] Free fatty acid receptor 2 (G-protein coupled receptor 43) (Leukocyte-specific STAT-induced GPCR)
[Ffar1 Gpr40] Free fatty acid receptor 1 (G-protein coupled receptor 40)
[FFAR4 GPR120 GPR129 O3FAR1 PGR4] Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1)
[FFAR1 GPR40] Free fatty acid receptor 1 (G-protein coupled receptor 40)
[Ffar4 Gpr120 O3far1] Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor GT01) (Omega-3 fatty acid receptor 1)
[Ffar3 Gm478 Gpr41] Free fatty acid receptor 3 (G-protein coupled receptor 41)
[PSMB5 LMPX MB1 X] Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X)
[Ffar2 Gpr43] Free fatty acid receptor 2 (G-protein coupled receptor 43)
[Ffar3 Gpr41] Free fatty acid receptor 3 (G-protein coupled receptor 41)
[LCB3 LBP1 YSR2 YJL134W J0671] Dihydrosphingosine 1-phosphate phosphatase LCB3 (EC 3.1.3.-) (Long-chain base protein 3) (Sphingolipid resistance protein 2)
[Sptlc2 Lcb2] Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)
[SPTLC3 C20orf38 SPTLC2L] Serine palmitoyltransferase 3 (EC 2.3.1.50) (Long chain base biosynthesis protein 2b) (LCB2b) (Long chain base biosynthesis protein 3) (LCB 3) (Serine-palmitoyl-CoA transferase 3) (SPT 3)
[SPTLC2 KIAA0526 LCB2] Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)
[VPS51 ANG2 C11orf2 C11orf3 FFR PP5382] Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog)
[LCB1 END8 TSC2 YMR296C] Serine palmitoyltransferase 1 (SPT 1) (SPT1) (EC 2.3.1.50) (Long chain base biosynthesis protein 1)
[YKL069W YKL340] Free methionine-R-sulfoxide reductase (fRMsr) (EC 1.8.4.14) (GAF domain-containing protein YKL069W)
[MYC] Myc proto-oncogene protein (Proto-oncogene c-Myc) (Transcription factor p64)
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[vps51 ffr] Vacuolar protein sorting-associated protein 51 homolog (Protein fat-free)
[RSB1 YOR049C O2787] Sphingoid long-chain base transporter RSB1
[PRE2 DOA3 PRG1 YPR103W P8283.10] Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain subunit PRE2) (Multicatalytic endopeptidase complex subunit PRE2) (Proteasome component PRE2) (Proteinase YSCE subunit PRE2)
[SBH1 At1g69640 F24J1.22 T6C23.16] Sphinganine C4-monooxygenase 1 (EC 1.14.18.5) (Sphingoid C4-hydroxylase 1) (Sphingoid base hydroxylase 1)
[LCB1 EMB2779 FBR11 At4g36480 AP22 C7A10.880] Long chain base biosynthesis protein 1 (AtLCB1) (EC 2.3.1.50) (Protein EMBRYO DEFECTIVE 2779) (Protein FUMONISIN B1 RESISTANT 11)
[PIL1 YGR086C] Sphingolipid long chain base-responsive protein PIL1

Bibliography :
[30407092] A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis.
[29456035] A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis.
[25363231] NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.
[23201127] Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease.
[23136226] Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma.
[22920643] The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
[21228035] Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
[21384738] Successful treatment of early relapse of ocular myeloma with bortezomib and steroid after autologous stem cell transplantation.